ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Videos | Radiation Therapy
VIDEO: Elekta Harmony Radiotherapy System Walk-around

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of an Ion Beam Radiotherapy Treatment System

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of a Multileaf Collimator (MLC) on a Radiotherapy System

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Videos | Radiation Therapy
VIDEO: 4 Radiation Oncology Technologies to Watch

Anthony Zietman, M.D., interim chief, radiation oncology, Mass General Cancer Center, and former president of the ...

Time November 15, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of Synthetic CT Datasets Made From MRI for Radiotherapy Treatment Planning

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
arrow
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that the American Medical Association (AMA) has issued a new, dedicated current procedural terminology (CPT) proprietary laboratory analyses (PLA) code for DCISionRT, the only test available to predict personalized recurrence risk and radiation therapy benefit for patients with ductal carcinoma in situ (DCIS).
News | Radiation Oncology
American Medical Association Grants PreludeDx a CPT PLA Code for Proprietary DCISionRT Test

November 12, 2021 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early ...

Time November 12, 2021
arrow
Videos | Oncology Information Management Systems (OIMS)
VIDEO Example of the Varian Noona Bidirection Oncology Patient Interface Software

An example of the Varian Noona software used by clinicians to interface with oncology patients demonstrated at the ...

Time November 12, 2021
arrow
Videos | Radiation Therapy
VIDEO: Reflexion Radiation Therapy System Walk-around at ASTRO 2021

This is Reflexion’s X1 LINAC radiotherapy system on display at ASTRO 2021. It recently gained FDA clearance for standard ...

Time November 11, 2021
arrow
Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting suggest the company’s Decipher Prostate genomic classifier identifies patients with clinically high-risk prostate cancer who may require treatment intensification beyond standard-of-care therapy
News | Prostate Cancer
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer

November 11, 2021 — Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology ...

Time November 11, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of a Flexible Custom Bolus for EBRT

An example of flexible bolus made from silicone on molds that were 3-D printed from patient CT scans. These are very ...

Time November 11, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of Cherenkov Radiation Imaging During Radiation Therapy

DoseOptic gained FDA clearance in 2020 for its Cherenkov radiation imaging system for use during radiation therapy ...

Time November 11, 2021
arrow
Steven Chmura, M.D., Ph.D., University of Chicago, speaks at an ASTRO 2021 press conference on the results of a phase 1 clinical trial testing the effects of stereotactic body radiotherapy for treating multiple metastases. His study determined that treatments used for single tumors can also be safely used for treating patients with multiple metastases. Read more on this study.
Feature | ASTRO
Radiation Oncology Research Featured at ASTRO 2021

November 8, 2021 — The following links to all the highlighted sessions presented at the American Society for Radiation ...

Time November 08, 2021
arrow
A radiotherapy treatment plan for Accuray’s Tomotherapy system to kill white blood cells prior to a liver cancer patient undergoing a transplant. The treatment is aimed at the bone marrow and spares dose to most of the organs to reduce side effects. This was an example plan created on the new Volvo Ultra treatment planning system. The software allow planning for more than 100 cm of anatomy. It also allows users to drag target dose values of the main graph and the system will recalculate all the doses.
Gallery | ASTRO | By Dave Fornell, ITN Editor
Photo Gallery of Technologies at ASTRO 2021

This is an image gallery of technologies on display on the expo floor at the 2021 American Society of Radiation Oncology ...

Time November 08, 2021
arrow
recent research on personalized treatment for HPV-associated oropharyngeal cancer – particularly for patients with an inherited variant KRAS gene
News | Radiation Oncology
Identifying Unique Genetic Variants to Overcome Cancer Treatment Barriers

November 5, 2021 — Robert Chin, M.D., Ph.D., a radiation oncologist with UCLA Jonsson Comprehensive Cancer Center, will ...

Time November 05, 2021
arrow
The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare and Medicaid Services (CMS)
News | Radiation Oncology
ASTRO Deeply Concerned and Disappointed Over CMS 2022 Final Rules

November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura ...

Time November 03, 2021
arrow
A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.
Feature | Radiology Business | Melinda Taschetta-Millane
Top 10: Most Popular Radiology Technology Content in October 2021

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of ...

Time November 02, 2021
arrow
FLASH therapy, powered by the use of Varian’s ProBeam, is an experimental treatment modality delivering radiation therapy at ultra-high dose rates, in typically less than one second.
News | Proton Therapy
Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01

November 2, 2021 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center ...

Time November 02, 2021
arrow
Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring
News | ASTRO
Philips Highlights New Patient-centered Innovations at ASTRO 2021

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the ...

Time November 02, 2021
arrow
Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS)  (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).
News | Radiation Therapy
PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

Time November 02, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now